The present invention provides compounds of the following structure; A-Q-B--C-D that are useful for treating conditions or disorders associated with DGAT1 activity in animals, particularly humans.

 
Web www.patentalert.com

< Method of cloning animals

> N-Substituted-Heterocycloalkyloxybenzamide Compounds and Methods of Use

> ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
~ 00533